跳至主要内容
临床试验/NCT03044561
NCT03044561Unknown4 期

Effect of Sildenafil Citrate on the Outcome of in Vitro Fertilization After Multiple IVF Failures Attributed to Poor Endometrial Development

Ain Shams University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2017年1月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
80
试验地点
1
主要终点
endometrial thickness measures

研究概览

简要总结

The aim of this study is to evaluate the effect of sildenafil citrate on endometrial development in women with history of recurrent implantation failure after IVF

详细描述

sildenafil citrate may increase endometrial thickness in women with recurrent IVF failure attributed to poor endometrial development

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • (1) cases of infertility, older than 20 years of age and not older than 40 years.
  • (2) Body mass index (BMI):20-
  • (3) women have experienced two or more implantation failure attributed to inadequate endometrial development.

排除标准

  • (1) Uterine abnormalities (e.g. septate, bicornuate and fibroid uterus, Asherman Syndrome).
  • (2) Any contraindication to sildenafil citrate or any of the components of its formulation including:
  • Concurrent use of organic nitrites and nitrates.
  • Severe hepatic impairment.
  • Severe renal impairment.
  • Hypotension.
  • Recent stroke or heart attack.

研究组 & 干预措施

Sildenafil citrate

Experimental

干预措施: Sildenafil Citrate (Drug)

placebo

Placebo Comparator

干预措施: matching placebo (Drug)

结局指标

主要结局

endometrial thickness measures

时间窗: 21 days

we will measure endometrial thickness by US in women with recurrent implantation failure

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amr El-Sayed

principal investigator

Ain Shams University

研究点 (1)

Loading locations...

相似试验

Sildenafil Citrate of in Vitro Fertilization After... | 临床试验